Overall, based on prognostic values in sarcoma patients, overexpression in soft tissue sarcomas as compared with normal tissues and the sensitivity of the epithelioid sarcoma cell line to CHIR99021, we considered GSK-3β a potential drug target worthy of further investigation. This evidence concerns the gene GSK3B and sarcoma.